|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02126 JW THERAP-B
Nominal 
1.470 +0.120 (+8.889%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -31.109% | -28.644% | -20.369% | -74.809% | -125.467% |
| ROAE (%) | -38.037% | -32.891% | -22.581% | -133.779% | N/A |
| Return on Capital Employed (%) | -40.816% | -34.111% | -24.071% | -46.968% | -116.023% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 50.743% | 40.326% | 29.370% | N/A | N/A |
| EBITDA Margin (%) | -398.032% | -529.212% | -2150.482% | N/A | N/A |
| Pre-tax Profit Margin (%) | -441.743% | -580.730% | -2280.508% | N/A | N/A |
| Net Profit Margin (%) | -441.743% | -580.730% | -2280.508% | N/A | N/A |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 4.036 X | 4.778 X | 9.528 X | 11.168 X | 2.128 X |
| Quick Ratio (X) | 3.905 X | 4.649 X | 9.370 X | 11.164 X | 2.128 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 21.540% | 15.658% | 10.452% | 9.254% | 240.938% |
| Total Debt / Total Assets (%) | 14.855% | 10.000% | 4.718% | 3.270% | 11.633% |
| Net Debt / Total Assets (%) | -32.017% | -39.558% | -54.141% | -66.332% | -26.485% |
| Total Debt / Shareholders' Funds (%) | 18.933% | 11.856% | 5.268% | 3.604% | N/A |
| Long Term Debt / Shareholders' Funds (%) | 11.746% | 5.362% | 4.545% | 3.286% | N/A |
| Net Debt / Shareholders' Funds (%) | -40.806% | -46.902% | -60.460% | -73.096% | N/A |
| Net Cash / (Debt) ($) | 687.114M | 1.104B | 1.687B | 2.507B | 177.083M |
| Net Cash / (Debt) per share ($) | 1.666 | 2.686 | 4.139 | 6.463 | -- |
| Total Debt / Capital Employed (%) | 16.943% | 11.253% | 5.039% | 3.489% | 14.251% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 159.697 Day | 150.207 Day | 271.476 Day | -- | -- |
| Receivables Turnover (Day) | N/A | 13.290 Day | N/A | N/A | N/A |
| Payables Turnover (Day) | 11.414 Day | 12.737 Day | 20.545 Day | N/A | N/A |
| Remarks: | Real time quote last updated: 08/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -240,267,000 |
| %Change | -36.841% |
| EPS / (LPS) | RMB -0.580 |
| NBV Per Share (¥) | RMB 3.570 |